The company was named after the Greek word translated as pharmakeia, which means sorcery.
Amersham[ edit ] In the biotechnology division of the company Pharmacia Biotech merged with Amersham Life Science with the new merged entity being known as Amersham Pharmacia Biotech. Inthe nutrition division of the company was sold to Fresenius.
Monsanto[ edit ] Monsanto acquired the pharmaceutical company G. A decade later the revamped subsidiary Searle and the Monsanto Pharma Sector invented and developed celecoxib.
Branded as Celebrex, celecoxib is an anti-inflammatory drug that became widely used soon after its approval by the FDA at the end of Pfizer[ edit ] In JulyPharmacia Corp. Inthe allergy-diagnostic division of Pharmacia was sold off as Pharmacia Diagnostics.
Later inthe Uppsala-based ophthalmology division was sold to Advanced Medical Optics. On January 16,Pharmacia Diagnostics announced that its name was changed to Phadiawhich has ended the use of the Pharmacia trademark. The remnant of Pharmacia was sold to the Indian company Kemwell in The rest was moved to Belgium in The following is an illustration of the company's mergers, acquisitions, spin-offs and historical predecessors:Dec 20, · Monsanto stockholders will exchange each of their shares for a share of the combined company in the transaction, described as a merger of equals without a premium for shareholders.
Pharmacia shareholders will receive shares for each of their shares, a % discount, based on Friday prices. Pharmacia & Upjohn and Monsanto also said in a statement issued Sunday that the new company's integrated agricultural business will probably be spun off in an initial public offering.
The new company's pharmaceutical business will be headquartered in Peapack, N.J., where Pharmacia is based, and the agricultural-chemical business will be headquartered in Monsanto's hometown of St. Louis. Aug 21, · The new company, to be named Pharmacia & Upjohn Inc., would become the world's ninth-largest pharmaceutical firm, with annual sales of nearly $7 billion.
Monsanto, Pharmacia & Upjohn Agree to Merge Reuters | December 19, | By Emily Kaiser CHICAGO - Life sciences firm Monsanto Co. and U.S.-Swedish drug group Pharmacia & Upjohn Inc. said on Sunday they agreed to merge, forming a company with a market capitalisation of more than $50 billion and an enviable collection of .
CHICAGO - Life sciences firm Monsanto Co. and U.S.-Swedish drug group Pharmacia & Upjohn Inc.
said on Sunday they agreed to merge, forming a company with a market capitalisation of more than $50 billion and an enviable collection of blockbuster drugs.